Sanofi has removed a clutch of programs from its clinical pipeline, scratching out entries for its late-phase BTK inhibitor and phase 1 prospects linked to the multibillion-dollar takeovers of Ablynx, ...

Learn more about whether Biogen Inc. or Natera, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Many celebrity children hang back from the limelight for a time, often at their parents' behest. Sooner or later though, the ...

The M4 MacBook Air is about to launch, so what should you expect when it hits store shelves? Here’s everything we know about ...